Clinical utility of microvolt T-wave alternans testing in identifying patients at high or low risk of sudden cardiac death

Faisal M. Merchant, Takanori Ikeda, Roberto F E Pedretti, Jorge A. Salerno-Uriarte, Theodore Chow, Paul S. Chan, Cheryl Bartone, Stefan H. Hohnloser, Richard J. Cohen, Antonis A. Armoundas

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Background: Previous studies have demonstrated that microvolt T-wave alternans (MTWA) testing is a robust predictor of ventricular tachyarrhythmias and sudden cardiac death (SCD) in at-risk patients. However, recent studies have suggested that MTWA testing is not as good a predictor of " appropriate" implantable cardioverter-defibrillator (ICD) therapy as it is a predictor of SCD in patients without ICDs. Objective: To evaluate the utility of MTWA testing for SCD risk stratification in patients without ICDs. Methods: Patient-level data were obtained from 5 prospective studies of MTWA testing in patients with no history of ventricular arrhythmia or SCD. In these studies, ICDs were implanted in only a minority of patients and patients with ICDs were excluded from the analysis. We conducted a pooled analysis and examined the 2-year risk for SCD based on the MTWA test result. Results: The pooled cohort included 2883 patients. MTWA testing was positive in 856 (30%), negative in 1627 (56%), and indeterminate in 400 (14%) patients. Among patients with a left ventricular ejection fraction (LVEF) of ≤35%, annual SCD event rates were 4.0%, 0.9%, and 4.6% among groups with MTWA positive, negative, and indeterminate test results. The SCD rate was significantly lower among patients with a negative MTWA test result than in patients with either positive or indeterminate MTWA test results (P 35%, annual SCD event rates were 3.0%, 0.3%, and 0.3% among the groups with MTWA positive, negative, and indeterminate test results. The SCD rate associated with a positive MTWA test result was significantly higher than that associated with either negative (P 35%, a positive MTWA test result identifies patients at significantly heightened SCD risk. These findings may have important implications for refining primary prevention ICD treatment algorithms.

Original languageEnglish
JournalHeart Rhythm
Volume9
Issue number8
DOIs
Publication statusPublished - Aug 2012

Fingerprint

Sudden Cardiac Death
Mortality
Implantable Defibrillators
Primary Prevention
Tachycardia
Stroke Volume
Cardiac Arrhythmias

Keywords

  • Arrhythmia
  • heart failure
  • ICD
  • Risk stratification
  • Sudden cardiac death
  • T-wave alternans

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Clinical utility of microvolt T-wave alternans testing in identifying patients at high or low risk of sudden cardiac death. / Merchant, Faisal M.; Ikeda, Takanori; Pedretti, Roberto F E; Salerno-Uriarte, Jorge A.; Chow, Theodore; Chan, Paul S.; Bartone, Cheryl; Hohnloser, Stefan H.; Cohen, Richard J.; Armoundas, Antonis A.

In: Heart Rhythm, Vol. 9, No. 8, 08.2012.

Research output: Contribution to journalArticle

Merchant, FM, Ikeda, T, Pedretti, RFE, Salerno-Uriarte, JA, Chow, T, Chan, PS, Bartone, C, Hohnloser, SH, Cohen, RJ & Armoundas, AA 2012, 'Clinical utility of microvolt T-wave alternans testing in identifying patients at high or low risk of sudden cardiac death', Heart Rhythm, vol. 9, no. 8. https://doi.org/10.1016/j.hrthm.2012.03.014
Merchant, Faisal M. ; Ikeda, Takanori ; Pedretti, Roberto F E ; Salerno-Uriarte, Jorge A. ; Chow, Theodore ; Chan, Paul S. ; Bartone, Cheryl ; Hohnloser, Stefan H. ; Cohen, Richard J. ; Armoundas, Antonis A. / Clinical utility of microvolt T-wave alternans testing in identifying patients at high or low risk of sudden cardiac death. In: Heart Rhythm. 2012 ; Vol. 9, No. 8.
@article{47d442d2f669422990a6fccf30ce28ee,
title = "Clinical utility of microvolt T-wave alternans testing in identifying patients at high or low risk of sudden cardiac death",
abstract = "Background: Previous studies have demonstrated that microvolt T-wave alternans (MTWA) testing is a robust predictor of ventricular tachyarrhythmias and sudden cardiac death (SCD) in at-risk patients. However, recent studies have suggested that MTWA testing is not as good a predictor of {"} appropriate{"} implantable cardioverter-defibrillator (ICD) therapy as it is a predictor of SCD in patients without ICDs. Objective: To evaluate the utility of MTWA testing for SCD risk stratification in patients without ICDs. Methods: Patient-level data were obtained from 5 prospective studies of MTWA testing in patients with no history of ventricular arrhythmia or SCD. In these studies, ICDs were implanted in only a minority of patients and patients with ICDs were excluded from the analysis. We conducted a pooled analysis and examined the 2-year risk for SCD based on the MTWA test result. Results: The pooled cohort included 2883 patients. MTWA testing was positive in 856 (30{\%}), negative in 1627 (56{\%}), and indeterminate in 400 (14{\%}) patients. Among patients with a left ventricular ejection fraction (LVEF) of ≤35{\%}, annual SCD event rates were 4.0{\%}, 0.9{\%}, and 4.6{\%} among groups with MTWA positive, negative, and indeterminate test results. The SCD rate was significantly lower among patients with a negative MTWA test result than in patients with either positive or indeterminate MTWA test results (P 35{\%}, annual SCD event rates were 3.0{\%}, 0.3{\%}, and 0.3{\%} among the groups with MTWA positive, negative, and indeterminate test results. The SCD rate associated with a positive MTWA test result was significantly higher than that associated with either negative (P 35{\%}, a positive MTWA test result identifies patients at significantly heightened SCD risk. These findings may have important implications for refining primary prevention ICD treatment algorithms.",
keywords = "Arrhythmia, heart failure, ICD, Risk stratification, Sudden cardiac death, T-wave alternans",
author = "Merchant, {Faisal M.} and Takanori Ikeda and Pedretti, {Roberto F E} and Salerno-Uriarte, {Jorge A.} and Theodore Chow and Chan, {Paul S.} and Cheryl Bartone and Hohnloser, {Stefan H.} and Cohen, {Richard J.} and Armoundas, {Antonis A.}",
year = "2012",
month = "8",
doi = "10.1016/j.hrthm.2012.03.014",
language = "English",
volume = "9",
journal = "Heart Rhythm",
issn = "1547-5271",
publisher = "Elsevier",
number = "8",

}

TY - JOUR

T1 - Clinical utility of microvolt T-wave alternans testing in identifying patients at high or low risk of sudden cardiac death

AU - Merchant, Faisal M.

AU - Ikeda, Takanori

AU - Pedretti, Roberto F E

AU - Salerno-Uriarte, Jorge A.

AU - Chow, Theodore

AU - Chan, Paul S.

AU - Bartone, Cheryl

AU - Hohnloser, Stefan H.

AU - Cohen, Richard J.

AU - Armoundas, Antonis A.

PY - 2012/8

Y1 - 2012/8

N2 - Background: Previous studies have demonstrated that microvolt T-wave alternans (MTWA) testing is a robust predictor of ventricular tachyarrhythmias and sudden cardiac death (SCD) in at-risk patients. However, recent studies have suggested that MTWA testing is not as good a predictor of " appropriate" implantable cardioverter-defibrillator (ICD) therapy as it is a predictor of SCD in patients without ICDs. Objective: To evaluate the utility of MTWA testing for SCD risk stratification in patients without ICDs. Methods: Patient-level data were obtained from 5 prospective studies of MTWA testing in patients with no history of ventricular arrhythmia or SCD. In these studies, ICDs were implanted in only a minority of patients and patients with ICDs were excluded from the analysis. We conducted a pooled analysis and examined the 2-year risk for SCD based on the MTWA test result. Results: The pooled cohort included 2883 patients. MTWA testing was positive in 856 (30%), negative in 1627 (56%), and indeterminate in 400 (14%) patients. Among patients with a left ventricular ejection fraction (LVEF) of ≤35%, annual SCD event rates were 4.0%, 0.9%, and 4.6% among groups with MTWA positive, negative, and indeterminate test results. The SCD rate was significantly lower among patients with a negative MTWA test result than in patients with either positive or indeterminate MTWA test results (P 35%, annual SCD event rates were 3.0%, 0.3%, and 0.3% among the groups with MTWA positive, negative, and indeterminate test results. The SCD rate associated with a positive MTWA test result was significantly higher than that associated with either negative (P 35%, a positive MTWA test result identifies patients at significantly heightened SCD risk. These findings may have important implications for refining primary prevention ICD treatment algorithms.

AB - Background: Previous studies have demonstrated that microvolt T-wave alternans (MTWA) testing is a robust predictor of ventricular tachyarrhythmias and sudden cardiac death (SCD) in at-risk patients. However, recent studies have suggested that MTWA testing is not as good a predictor of " appropriate" implantable cardioverter-defibrillator (ICD) therapy as it is a predictor of SCD in patients without ICDs. Objective: To evaluate the utility of MTWA testing for SCD risk stratification in patients without ICDs. Methods: Patient-level data were obtained from 5 prospective studies of MTWA testing in patients with no history of ventricular arrhythmia or SCD. In these studies, ICDs were implanted in only a minority of patients and patients with ICDs were excluded from the analysis. We conducted a pooled analysis and examined the 2-year risk for SCD based on the MTWA test result. Results: The pooled cohort included 2883 patients. MTWA testing was positive in 856 (30%), negative in 1627 (56%), and indeterminate in 400 (14%) patients. Among patients with a left ventricular ejection fraction (LVEF) of ≤35%, annual SCD event rates were 4.0%, 0.9%, and 4.6% among groups with MTWA positive, negative, and indeterminate test results. The SCD rate was significantly lower among patients with a negative MTWA test result than in patients with either positive or indeterminate MTWA test results (P 35%, annual SCD event rates were 3.0%, 0.3%, and 0.3% among the groups with MTWA positive, negative, and indeterminate test results. The SCD rate associated with a positive MTWA test result was significantly higher than that associated with either negative (P 35%, a positive MTWA test result identifies patients at significantly heightened SCD risk. These findings may have important implications for refining primary prevention ICD treatment algorithms.

KW - Arrhythmia

KW - heart failure

KW - ICD

KW - Risk stratification

KW - Sudden cardiac death

KW - T-wave alternans

UR - http://www.scopus.com/inward/record.url?scp=84864446744&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864446744&partnerID=8YFLogxK

U2 - 10.1016/j.hrthm.2012.03.014

DO - 10.1016/j.hrthm.2012.03.014

M3 - Article

C2 - 22406384

AN - SCOPUS:84864446744

VL - 9

JO - Heart Rhythm

JF - Heart Rhythm

SN - 1547-5271

IS - 8

ER -